Kallo Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KALO research report →
Companywww.kalloinc.ca
Kallo Inc. , together with its subsidiaries, focuses on developing medical information technology software. The company's products in development include Electronic Medical Records (EMR) Integration Engine, a software, which connects various other applications in or outside a hospital/clinic with the EMR system; Communicable and Infectious Disease Information Management System, an Internet-based solution for monitoring and managing communicable and infectious disease information; and Clinical-Care Globalization, a clinical-care globalization technology.
- CEO
- John Cecil
- IPO
- 2007
- Employees
- 2
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $1.91M
- P/E
- -0.08
- P/S
- 0.00
- P/B
- -0.11
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 33.24%
- ROIC
- 166.43%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-8,204,871 · 77.31%
- EPS
- $-0.00 · 88.57%
- Op Income
- $-7,970,779
- FCF YoY
- -259.73%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.70
- Avg Volume
- 0
Get TickerSpark's AI analysis on KALO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KALO Coverage
We haven't published any research on KALO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KALO Report →